PACB financials
Pacific Biosciences (PACB) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
PACB income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 | $160.00M | $50.67M | -$557.56M | -$546.38M | -1.82 |
| 2024 | $154.01M | $37.28M | -$474.31M | -$309.85M | -1.07 |
| 2023 | $200.52M | $52.78M | -$334.47M | -$306.74M | -1.21 |
| 2022 | $128.30M | $49.03M | -$307.20M | -$314.25M | -1.40 |
| 2021 | $130.51M | $58.86M | -$210.44M | -$181.22M | -0.89 |
| 2020 | $78.89M | $32.57M | -$104.39M | $29.40M | 0.17 |
- PACB revenue was $160.00M in fiscal 2025, net income -$546.38M.
Updated 2026-11-02 23:13 UTC